FDA Inspection
Southern Legacy of LifeSouthern Legacy of Life – FDA Inspection, Jul 25, 2018
Record Details
This FDA Inspection record concerns Southern Legacy of Life, with an inspection on July 25, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 70941d7c-362b-4d79-b9d5-fb651353d640
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1063371
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Southern Legacy of Life
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 13, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 26, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| May 16, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 7, 2012 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 8, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Southern Legacy of Life
- FDA Inspection 1332584 - 2026-08-13
- FDA Inspection 1198079 - 2023-01-26
- FDA Inspection 971852 - 2016-05-16
- FDA Inspection 809996 - 2012-12-07
- FDA Inspection 709627 - 2011-02-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.